82
Views
23
CrossRef citations to date
0
Altmetric
Drug Evaluation

Rituximab: review and clinical applications focusing on non-Hodgkin’s lymphoma

&
Pages 177-186 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Keith L Knutson, Lupe Salazar, Kathy Schiffman & Mary L Disis. (2003) Immunotherapy of glioblastoma multiforme. Expert Review of Neurotherapeutics 3:4, pages 511-523.
Read now

Articles from other publishers (21)

Alessio Ugolini & Marianna Nuti. (2021) Rheumatoid Factor: A Novel Determiner in Cancer History. Cancers 13:4, pages 591.
Crossref
Wen-Wei Lin, Yun-Chi Lu, Chih-Hung Chuang & Tian-Lu Cheng. (2020) Ab locks for improving the selectivity and safety of antibody drugs. Journal of Biomedical Science 27:1.
Crossref
Vivian H. Trang, Xinqun Zhang, Roma C. Yumul, Weiping Zeng, Ivan J. Stone, Serena W. Wo, Melissa M. Dominguez, Julia H. Cochran, Jessica K. Simmons, Maureen C. Ryan, Robert P. Lyon, Peter D. Senter & Matthew R. Levengood. (2019) A coiled-coil masking domain for selective activation of therapeutic antibodies. Nature Biotechnology 37:7, pages 761-765.
Crossref
Stefan H. E. Kaufmann. (2019) Immunology's Coming of Age. Frontiers in Immunology 10.
Crossref
Luis Mario Villela-Ma, Ana Karen Velez-Ayal, Rosa del Carmen Lopez-Sanc, Jorge A Martinez-C & Jose A Hernandez-. (2017) Advantages of Drug Selective Distribution in Cancer Treatment: Brentuximab Vedotin. International Journal of Pharmacology 13:7, pages 785-807.
Crossref
Nadia L. Al-Youssef, Shahrokh M. Ghobadloo & Maxim V. Berezovski. (2016) Inhibition of complement dependent cytotoxicity by anti-CD20 aptamers. RSC Advances 6:15, pages 12435-12438.
Crossref
Henrique Neves & Hang Fai Kwok. (2015) Recent advances in the field of anti-cancer immunotherapy. BBA Clinical 3, pages 280-288.
Crossref
Ricardo Ibarra-Cabrera, Sandra Carolina Mena-Pérez, Augusto Bondani-Guasti & Roeb García-Arrazola. (2013) Review on the worldwide regulatory framework for biosimilars focusing on the Mexican case as an emerging market in Latin America. Biotechnology Advances 31:8, pages 1333-1343.
Crossref
Amresh Raina & Raymond L Benza. (2012) Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials. Clinical Investigation 2:5, pages 491-501.
Crossref
Hung-Wei Chih, Benson Gikanga, Yi Yang & Boyan Zhang. (2011) Identification of Amino Acid Residues Responsible for the Release of Free Drug from an Antibody–Drug Conjugate Utilizing Lysine–Succinimidyl Ester Chemistry. Journal of Pharmaceutical Sciences 100:7, pages 2518-2525.
Crossref
Vinay Chaudhry & David R. Cornblath. (2010) An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy. Journal of the Peripheral Nervous System 15:3, pages 196-201.
Crossref
Richard M. Lewis & Mary Ellen Cosenza. (2010) Summary of DIA Workshop: Comparability Challenges: Regulatory and Scientific Issues in the Assessment of Biopharmaceuticals. Drug Information Journal 44:4, pages 485-504.
Crossref
Peter D. Senter & Damon L. Meyer. 2007. Prodrugs. Prodrugs 507 524 .
Paul S. Gaynon. (2005) Childhood acute lymphoblastic leukaemia and relapse. British Journal of Haematology 131:5, pages 579-587.
Crossref
Sam S. Yoon, Daniel G. Coit, Carol S. Portlock & Martin S. Karpeh. (2004) The Diminishing Role of Surgery in the Treatment of Gastric Lymphoma. Annals of Surgery 240:1, pages 28-37.
Crossref
Yoav Avidor, Nicola J. Mabjeesh & Haim Matzkin. (2003) Biotechnology and Drug Discovery: From Bench to Bedside. Southern Medical Journal 96:12, pages 1174-1186.
Crossref
Joseph A. FranciscoCharles G. CervenyDamon L. MeyerBruce J. MixanKerry KlussmanDana F. ChaceStarr X. RejniakKristine A. GordonRon DeBlancBrian E. TokiChe-Leung LawSvetlana O. DoroninaClay B. SiegallPeter D. SenterAlan F. Wahl. (2003) cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood 102:4, pages 1458-1465.
Crossref
Keith L Knutson, Tyler J Curiel, Lupe Salazar & Mary L Disis. (2003) Immunologic principles and immunotherapeutic approaches in ovarian cancer. Hematology/Oncology Clinics of North America 17:4, pages 1051-1073.
Crossref
Svetlana O Doronina, Brian E Toki, Michael Y Torgov, Brian A Mendelsohn, Charles G Cerveny, Dana F Chace, Ron L DeBlanc, R Patrick Gearing, Tim D Bovee, Clay B Siegall, Joseph A Francisco, Alan F Wahl, Damon L Meyer & Peter D Senter. (2003) Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nature Biotechnology 21:7, pages 778-784.
Crossref
Khaled Greish, Jun Fang, Takao Inutsuka, Akinori Nagamitsu & Hiroshi Maeda. (2003) Macromolecular Therapeutics. Clinical Pharmacokinetics 42:13, pages 1089-1105.
Crossref
Damon L. Meyer & Peter D. Senter. 2003. 229 237 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.